Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings https://ir.acurxpharma.com/all-sec-filings/rss Acurx Pharmaceuticals, Inc. (ACXP) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_bc17bec678b4603a27e19e495b3b9f86/acurxpharma/logo.png Acurx Pharmaceuticals, Inc. Logo https://ir.acurxpharma.com Equisolve Investor Relations Suite <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-550-9999999995-26-003000 Fri, 18 Sep 26 06:05:08 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-550-9999999995-26-003000 <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-549-0001104659-26-108599 Thu, 17 Sep 26 16:53:27 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-549-0001104659-26-108599 <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-545-0001104659-26-105917 Tue, 08 Sep 26 16:28:07 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-545-0001104659-26-105917 <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-544-0001104659-26-104320 Tue, 01 Sep 26 16:19:01 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-544-0001104659-26-104320 <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-543-0001104659-26-104319 Tue, 01 Sep 26 16:17:31 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-543-0001104659-26-104319 <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-542-0001104659-26-104316 Tue, 01 Sep 26 16:16:54 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-542-0001104659-26-104316 <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-537-0001104659-26-095904 Thu, 13 Aug 26 16:28:03 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-537-0001104659-26-095904 <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578 Tue, 12 May 26 06:07:09 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-525-9999999995-26-001578 <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577 Tue, 12 May 26 06:07:01 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-524-9999999995-26-001577 <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298 Tue, 12 May 26 15:05:23 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-527-0001104659-26-059298